These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11761950)
61. [Is pulsed Doppler ultrasonography more useful for the therapeutic monitoring of hepatocellular carcinoma than for its diagnosis?]. Burtin P Gastroenterol Clin Biol; 1992; 16(4):377-8. PubMed ID: 1327931 [No Abstract] [Full Text] [Related]
62. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization. Tanaka K; Inoue S; Numata K; Takamura Y; Takebayashi S; Ohaki Y; Misugi K AJR Am J Roentgenol; 1992 Mar; 158(3):541-6. PubMed ID: 1310826 [TBL] [Abstract][Full Text] [Related]
63. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Choi BI; Kim TK; Han JK; Chung JW; Park JH; Han MC Radiology; 1996 Jul; 200(1):55-8. PubMed ID: 8657945 [TBL] [Abstract][Full Text] [Related]
64. [Diagnosis of small hepatocellular carcinoma by US angiography with intraarterial CO2 microbubbles imaging]. Yamamoto K; Okuda Y Nihon Rinsho; 1998 Apr; 56(4):951-5. PubMed ID: 9577615 [TBL] [Abstract][Full Text] [Related]
65. [Doppler and color Doppler ultrasound diagnosis in differentiation of focal liver lesions]. Paintner A; Bayer C; Böttcher B; Wenk H; Swobodnik W Bildgebung; 1996 Mar; 63(1):22-6. PubMed ID: 8653004 [TBL] [Abstract][Full Text] [Related]
66. Flow characteristics of hepatic tumors at color Doppler sonography: correlation with arteriographic findings. Numata K; Tanaka K; Mitsui K; Morimoto M; Inoue S; Yonezawa H AJR Am J Roentgenol; 1993 Mar; 160(3):515-21. PubMed ID: 8381573 [TBL] [Abstract][Full Text] [Related]
67. Use of hepatic tumor index on color Doppler sonography for differentiating large hepatic tumors. Numata K; Tanaka K; Kiba T; Morimoto M; Arata S; Kondo M; Sekihara H AJR Am J Roentgenol; 1997 Apr; 168(4):991-5. PubMed ID: 9124156 [TBL] [Abstract][Full Text] [Related]
68. Caution in the interpretation of Doppler signals of HCC. Gaiani S; Li Bassi S; Zironi G; Bolondi L; Barbara L Gastroenterology; 1990 Dec; 99(6):1860. PubMed ID: 2172074 [No Abstract] [Full Text] [Related]
69. [Liver cancer: progress in diagnosis and treatments. Topics: V. Progress in diagnosis of liver cancer; 1. Diagnosis of hepatocellular carcinoma by ultrasonography]. Numata K; Tanaka K Nihon Naika Gakkai Zasshi; 2014 Jan; 103(1):44-54. PubMed ID: 24605490 [No Abstract] [Full Text] [Related]
70. Emerging Evidence of the Utility of Perfluorobutane-enhanced US as a Diagnostic Test for Hepatocellular Carcinoma. Kim TK; Jang HJ Radiology; 2020 Oct; 297(1):117-119. PubMed ID: 32772877 [No Abstract] [Full Text] [Related]
71. Screening for liver cancer: another piece of the puzzle? Sherman M Hepatology; 2014 May; 59(5):1673-5. PubMed ID: 24254319 [No Abstract] [Full Text] [Related]
72. Reply: To PMID 24002724. Chen HH; Yeh YP; Lao CS; Hu TH; Yen AM; Wu WY Hepatology; 2015 Mar; 61(3):1092-3. PubMed ID: 25042409 [No Abstract] [Full Text] [Related]
73. Contrast-enhanced US Incorporating Kupffer-Phase Findings for the Diagnosis of Hepatocellular Carcinoma. Kim TK Radiology; 2023 Aug; 308(2):e231494. PubMed ID: 37642565 [No Abstract] [Full Text] [Related]
74. Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications. Krinsky G; Shanbhogue K Radiology; 2021 Sep; 300(3):583-585. PubMed ID: 34227887 [No Abstract] [Full Text] [Related]
75. Introduction to the special section on hepatocellular carcinoma treatment response. Mendiratta-Lala M; Yaghmai V Abdom Radiol (NY); 2021 Aug; 46(8):3527. PubMed ID: 34255128 [No Abstract] [Full Text] [Related]